Given the long prodromal period for Alzheimer's disease (AD), the lack of effective treatments, and the increasing prevalence associated with population aging, there is a need to identify population health approaches to reducing risk of the disease (Barnes et al. [@CR11]). Information on risk factors for Alzheimer's disease is obtained from individual cohort studies and meta-analyses of these studies. These studies differ in terms of the number of exposures measured at baseline, the length of follow-up and the sample characteristics. Importantly, risk factors for AD may vary over the adult life-course. In studies comprising only older adults, there is potential confounding of the effects of preclinical AD on risk scores. For example, body weight declines up to 6 years prior to AD diagnosis (Anstey et al. [@CR7]), as does serum cholesterol (Presecki et al. [@CR47]). Cognitive decline and brain changes occur many years prior to diagnosis yet may be due to the disease and hence not independent risk factors. Hence, no single study provides all the information required for the development of an ideal risk assessment tool for Alzheimer's disease.

The aim of this study was to use an Evidence-Based Medicine approach to develop a new approach to risk assessment for Alzheimer's disease that incorporates all the currently reliable information on risk factors. This methodology differs from that previously used to develop risk assessment indices for dementia because it is based on review of the extant literature, rather than analysis of a single cohort study. We chose to restrict the tool to risk factors that could be assessed via self-report so that the index can be implemented online in primary care and intervention studies, and used in large-scale population health programs. The methodology could potentially be used in relation to other areas of chronic disease for which there is a wide literature and need for long-term population-based prevention strategies.

Previous Risk Assessment Indices for Alzheimer's Disease and Dementia {#Sec1}
=====================================================================

Two risk indices have been developed for AD specifically (as opposed for the more general category 'dementia'). These have each been based on follow-up of a sample of already older adults, to identify statistical associations between baseline measures and later diagnosis of AD. The first was developed by Reitz et al. ([@CR49]) using data from the Northern Manhattan study (*n* = 1051, mean age 75.66) and includes sex, education, ethnicity, apolipoprotein E genotype, diabetes, hypertension, smoking, high density lipoproteins, and waist to hip ratio (Reitz et al. [@CR49]). Despite its strengths, this measure is not suitable for large-scale population-based studies because it depends on clinical assessment and genotyping. A second was developed from a German Primary Care patient registry and involved following up 3055 patients three times, at 18-month intervals. This study identified age, subjective memory complaint, cognitive function, depressive symptoms and Instrumental Activities of Daily Living (IADL) as predictors of conversion to AD (Jessen et al. [@CR27]). Ideally, a risk assessment tool will not include screening measures or other indices of current mild cognitive impairment (subjective memory complaints, cognitive impairment, impairment in IADL) to allow for separation of risk factors from the predicted outcome. Mild cognitive impairment is often pre-clinical AD (Lopez et al. [@CR39]). As cognitive decline is a core feature of dementia and AD, inclusion of cognitive function, particularly indexed by a dementia screening instrument, would mean the risk index is for use after cognitive decline has commenced and hence is less predictive prior to the onset of symptoms. The optimal risk assessment tool for prevention trials will not include items that may also be symptomatic of the disease.

Two risk indices for the broader diagnosis of dementia (of which AD is the most common cause) have also been reported in the literature. Kivipelto et al. developed a dementia risk index using data from CAIDE study (*n* = 1449) in 2006. They found that age, sex, education, hypertension, high cholesterol and obesity predicted dementia risk over a 20-year follow-up period (Kivipelto et al. [@CR31]). The particular strength of this index was the validation over a long follow-up period and inclusion of middle-aged participants in the baseline assessment; however, it was restricted to the variables available in the baseline assessment of a single study. A second dementia risk index was calculated using data from the Cardiovascular Health Cognition Study (*n* = 3608, mean baseline age 76 years). In this study, age, poor cognitive performance, low BMI, APOE genotype, white matter hyperintensities on brain MRI, ventricular enlargement, thickening of the carotid artery, history of bypass surgery, slow physical performance, and abstaining from alcohol were risk factors for dementia over 6 years (Barnes et al. [@CR10]). This scale is not suitable for population-based settings due to the inclusion of clinical measures. A brief version of this second risk index has also been reported (Barnes et al. [@CR11]) and includes age, some simple cognitive tests, self-report of attentional difficulties, stroke, peripheral artery disease, coronary artery bypass surgery, low BMI, and lack of alcohol consumption. Although this shorter version requires less expensive clinical assessments, it still requires cognitive assessment and detailed medical history obtained from a health professional and is derived from a single cohort study of older adults.

Previous dementia and AD risk indices were limited to the variables included in the studies on which they were based and to the characteristics of their cohorts such as age at exposure (typically the age of the cohort at baseline assessment). Hence, they do not take into account the fact that some risk factors differ in their association with AD over the adult life-course. For example, in mid-life both high cholesterol and high BMI are risk factors for AD but in late-life, neither is a risk factor for AD (Anstey et al. [@CR4], [@CR7]). Moreover, some risk factors may also be affected by the disease itself. Weight loss typically precedes AD by about 6 years, and hence low BMI may show up as a risk factor for AD in a study of older adults (e.g., Barnes et al. [@CR10]) when it is actually as symptom of AD (Knopman et al. [@CR32]).

It is notable that the two previously published risk indices for dementia described above found that opposite categories of BMI were associated with increased risk of dementia. This is a concrete example of the limitations of basing an index on a single cohort, and the different findings resulting from different baseline ages of the cohorts. Using the broader data available from the literature on each risk factor allows for inclusion of interactions between age and specific risk factors to capture their differing effects over the adult life course.

The present study aimed to develop a methodology for creating a self-report Alzheimer's Disease Risk Index that could be updated as new findings become available. The overall AD risk assessment tool was called the Australian National University Alzheimer's Disease Risk Index (ANU-ADRI). There are three main advantages of this approach. First, it does not limit the possible number of risk factors that may be included in the index. Second, it derives from the principles of Evidence Based Medicine that assume the most reliable estimates of effect sizes are obtained from the statistical analysis of the population of studies (Davidoff et al. [@CR17]; Lyman and Kuderer [@CR41]). Third, it allows for the full information about a putative risk or protective factor to be considered when designing the tool (e.g., the age of exposure relevant to the risk factor, gender effects, optimal measurement characteristics). This project builds on a series of systematic reviews of risk factors for dementia and Alzheimer\'s disease conducted by the authors (Anstey et al. [@CR3], [@CR4], [@CR5], [@CR7]).

Method {#Sec2}
======

There were four stages to the development of the ANU-ADRI outlined in Fig. [1](#Fig1){ref-type="fig"}.Fig. 1Flowchart showing stages of development of the ANU-ADRI

Development of a List of Putative Risk Factors and Protective Factors for AD that Can Be Measured by Self-report {#Sec3}
----------------------------------------------------------------------------------------------------------------

The first stage (Fig. [1](#Fig1){ref-type="fig"}) involved collating an initial list of possible risk factors for inclusion. This was collated from the comprehensive review of risk factors for Alzheimer's Disease and Cognitive Decline published (Williams et al. [@CR63]) and by the authors who had a thorough general knowledge of the literature obtained when conducting previous systematic reviews (Anstey et al. [@CR3], [@CR4], [@CR5], [@CR7]). A systematic search of review articles on risk factors for AD, and review articles on risk factors for AD were identified using PubMed search terms \[Dementia OR Alzheimer's disease OR Cognitive impairment\] AND \[Genetics, Age, Gender, Marital status, Family history of dementia, Family history of AD, Body Mass Index, Weight loss, Weight gain, Obesity, Occupation, Primary occupation, Diabetes mellitis, Depression, Hyperlipidaemia, Hypercholesterolemia, Cardiovascular disease, Myocardial Infarction, Angina, Ischemic heart disease, Heart failure, Cardiac failure, Arrhythmia, Atrial fibrillation, Stroke, Cerebrovascular accident, Transient ischemic attack, Hypertension, High blood pressure, Anxiety, Smoking, Alcohol, Omega 3 intake, Fish consumption, Physical activity, Exercise, Social network, Social engagement, Social activities, Cognitive leisure activities, Cognitive training, Brain training, Diet, Mediterranean diet, Fruit and vegetable intake, Total caloric intake, Fat intake, Caffeine, Antioxidants, Statin, anti-hypertensives, Hypertension treatments, Hormone Replacement Therapy, Oestrogen, Progesterone, NSAIDS, Vitamins, Nutritional supplements\].

The second stage involve selecting risk and protective factors from the initial list for which there was reliable evidence of an association with AD. Inclusion criteria were that there was evidence for the risk factor derived from a high quality meta-analysis or multiple high quality cohort studies from which a pooled effect size could be calculated. High quality studies and meta-analyses were defined using the criteria applied in previous systematic reviews by the authors (Anstey et al. [@CR3], [@CR4], [@CR5], [@CR7]; Williams et al. [@CR63]). Briefly, they had to be prospective, have greater than 100 subjects, more than 12 months follow-up, include population-based samples and widely accepted research criteria used to diagnose AD (e.g., DSM-IV criteria). Factors for which high quality meta-analyses were available that showed no significant association between the putative risk factor and AD were excluded (e.g., hypertension, non-steroidal anti-inflammatory drugs).

Selection of Odds Ratios for Inclusion in the AD Risk Index {#Sec4}
-----------------------------------------------------------

In the third stage, the odds ratios associated with risk and protective factors were derived from the literature using the following hierarchy of methods. First, odds ratios were extracted from systematic reviews where the exposure was clearly defined. If odds ratios were not available from systematic reviews, the authors identified high quality cohort studies and calculated odds ratios from pooled effect sizes. This occurred for education, traumatic brain injury,pesticide exposure, cognitive activity and social engagement (available online). If odds ratios were available but the exposure variable was not clearly defined in a manner that could be translated into a self-report questionnaire, the original and new high quality articles were located by authors and new pooled estimates calculated by the authors (e.g., high cholesterol and depressive symptoms) from articles reporting exposures that were translatable. In the case of physical activity, only one article contributing to the published pooled estimate reported odds ratios that could be translated into a measure and the results from this single article were used. In the case of cognitive activity, we obtained the raw data from authors and analysed it to determine cut-offs that could meaningfully be linked to cutoffs on the questionnaire used in these articles and then incorporated them into a self-report questionnaire. Where possible data were stratified by age of exposure, age of AD diagnosis, and sex.

Classification of Protective Factors {#Sec5}
------------------------------------

The ANU-ADRI includes both risk factors and protective factors rather than rescoring all factors as 'risk factors' because this reflects the way factors have been portrayed in the literature. Higher levels of physical activity, cognitive activity and high intake of fish are included as protective factors while low level of social engagement is included as a risk factor, consistent with the studies where these original findings were reported (Fotuhi et al. [@CR19]; Fratiglioni et al. [@CR20]; Williams et al. [@CR63]; Wilson et al. [@CR64]).

Selection of Questions for Inclusion in the AD Risk Assessment Tool {#Sec6}
-------------------------------------------------------------------

In the fourth stage, definitions of exposure variables for inclusion in the ANU Alzheimer's Disease Risk Index were determined. This led to the actual selection of questionnaire items for inclusion in the assessment tool (available online). Of risk factors identified for inclusion, the definitions of exposure variables were identified from the descriptions reported in articles reporting results of the relevant meta-analyses in the first instance. However, for some risk factors, the descriptions of the measures of the risk factors were not reported, but rather, generic categories created in the process of pooling the data were used in analyses (e.g., low physical activity versus high physical activity). In these instances we searched individual articles included in meta-analyses for exposure categories that could be linked to actual questionnaire items.

Methodology for the ANU-ADRI Scoring System {#Sec7}
-------------------------------------------

Individual ANU-ADRI scores were developed by creating an algorithm that sums the points attributed to individual risk factors using a previously published method (Kivipelto et al. [@CR31]; Zammit et al. [@CR65]). The points for each risk factor were obtained from the standardized beta-weights derived (from odds ratios of pooled effect sizes from meta-analyses). The lowest beta co-efficient (0.13) was given a score of one and other beta weights were standardized by multiplying them by 1/0.13 = 7.6923. An algorithm was written that sums the points attributed to individual risk factors (Kivipelto et al. [@CR31]; Zammit et al. [@CR65]) and incorporates interactions with age for relevant risk factors (high serum cholesterol, BMI) (Anstey et al. [@CR4], [@CR7]).

Results {#Sec8}
=======

Thirty-eight potential risk factors were identified, of which 13 were excluded due to insufficient evidence. Of the 25 remaining risk factors, 6 were excluded because they could not be assessed via self-report, and one (marital status) was incorporated into a broader category of social engagement in the actual measurement instruments. Another three risk factors were eliminated due to lack of evidence of an association with AD. This left 11 risk factors and 4 protective factors for inclusion in the ADRI. Table [1](#Tab1){ref-type="table"} reports the actual points attributed to each risk factor in the ANU-ADRI. Description of risk and protective factors and the source of effect sizes used in the ANU-ADRI are described below.Table 1Characteristics and sources of variables included in the ANU-ADRICharacteristicsBeta weightPointsSource of β weightAge for males \<65 yearsReference0Anstey et al. [@CR6] 65 years- 700.131Jorm et al. [@CR28] 70 years- 751.5712Access Economics [@CR1] 75 years- 802.0418Lobo et al. [@CR38] 80 years- 853.3726Ritchie and Kildea [@CR50] 85 years- 904.2433 \>904.9338Age for females \<65 yearsReference0 65 years- 700.645 70 years- 751.8714 75 years- 802.7521 80 years- 853.7129 85 years- 904.5835 \>90 years5.2841Education \>11 yearsReference0Launer et al. [@CR33]. Karp et al. [@CR29] 8 to 11 years0.423 \<8 years0.806BMI (age \< 60) NormalReference0Anstey et al. [@CR7] Overweight0.302 Obese0.715Diabetes No diabetesReference0Lu et al. [@CR40] Diabetes0.333Symptoms of depression CES-D \< 16Reference0Lenoir et al. [@CR35]; Saczynski et al. [@CR53]; Gatz et al. [@CR21]; Geerling et al. [@CR22]; Dal Forno et al. [@CR16] CES-D \> 16 Depression0.292High chol (aged \< 60) Not highReference0Anstey et al. [@CR4]; Mielke et al. [@CR42]; Solomon et al. [@CR58] High0.413TBI No TBIReference0Launer, et al. [@CR33]; Plassman et al. [@CR45]; Schofield et al. [@CR57] TBI0.464Smoking NeverReference0Anstey et al. [@CR3] Ever smoking0.191 Current0.584Alcohol intake No alcoholReference0Anstey et al. [@CR5] Light-mod-0.33-3Soc. engagement HighestReference0Fratiglioni et al. [@CR20]; Saczynski et al. [@CR54] Lowest0.846 Low to med0.514 Med to high0.171Physical activity LowestReference0Scarmeas et al. [@CR56] Medium-0.29-2 Higher level-0.40-3Cognitive activity LowestReference0Akbaraly et al. [@CR2]; Wilson et al. [@CR64] Middle-0.97-7 Highest-0.84-6Fish intake \<0.25 p p/weekReference0Huang et al. [@CR26] 0.25--2 p p/week-0.33-3 2--4 p p/week-0.53-4 \>4 p p/week-0.62-5Pesticide exposure NeverReference0Baldi et al. [@CR8]; Hayden et al. [@CR24]; Tyas et al. [@CR59] Ever0.312The points were derived by multiply the beta weights by 7.6923 and rounding up to an integer; TBI = traumatic brain injury; soc. = social; p p/week = portions per week

Demographics {#d30e1144}
------------

Odds ratios for age and gender were derived from population prevalence estimates of Alzheimer\'s disease in Australia, Europe and the USA (Anstey et al. [@CR6]; Jorm et al. [@CR28]; Access Economics [@CR1]; Lobo et al. [@CR38]; Ritchie and Kildea [@CR50]). A systematic review of 16 cohort studies and 6 case control studies found a reliable association between low education and risk of AD (*n* = 28025) (Caamano-Isorna et al. [@CR14]). However, this review compared the lowest education group with the highest education group, and the highest education group with any other level of education; hence, the results did not relate to categories that were appropriate for the ANU-ADRI. We therefore pooled data from four European studies reported in the Eurodem analyses (Launer et al. [@CR33]) and an additional study from a more recent meta-analysis (Caamano-Isorna et al. [@CR14]; Karp et al. [@CR29]) to produce the pooled estimate for education. Marital status was included as part of a social network measure described below and hence is not included as a separate demographic variable.

Diabetes {#d30e1180}
--------

Diabetes was identified as a risk factor for AD in a previous review (Williams et al. [@CR63]). The odds ratio for diabetes was obtained from a systematic review of 8 studies (*n* = 23257) that identified diabetes mellitus by self report plus use of anti-diabetic medications, or laboratory tests (Lu et al. [@CR40]; Williams et al. [@CR63]).

Depression {#d30e1197}
----------

A meta-analysis of depression and AD (*n* = 102172) (Ownby et al. [@CR44]) found that depression is a risk factor for AD. In this meta-analysis depression was defined according to diagnosis of depression or current symptoms and measures of depression included a range of clinical methods and scales, with validated cut-offs. In order to identify an odds ratio for use in the ANU-ADRI, we investigated both history of depression, and depression measured by symptom scales as a risk factor for AD because these were both obtained by self-report. We re-analysed the data from this meta-analysis and our review to pool four studies reporting a history of depression (Gatz et al. [@CR21]; Geerlings et al. [@CR22]; Li et al. [@CR36]; Lindsay et al. [@CR37]) and found that self-reported history of depression was not associated with AD. Of all symptom scales that could be administered by self-report, the Centre for Epidemiological Studies Depression Scale (CES-D 20-item scale) was included in the greatest number of cohort studies reporting effect sizes for the association between depressive symptoms and AD reflecting the wide use of this measure in high quality epidemiological studies. We therefore selected all studies reporting associations between depression and AD where depression had been measured using the CES-D from the Ownby et al. meta-analysis, and also searched the literature and identified two relevant studies that had been published after this review was published. The effect size for depression as a risk factor for AD was computed from five studies (Dal Forno et al. [@CR16]; Gatz et al. [@CR21]; Geerlings et al. [@CR22]; Li et al. [@CR36]; Lindsay et al. [@CR37]) and the 20-item CES-D was included in the ANU-ADRI.

Overweight BMI and Obesity {#d30e1236}
--------------------------

Odds ratios for mid-life overweight BMI and obese BMI were obtained from our recent meta-analysis of 15 cohort studies including 25624 participants followed for AD. BMI categories were classified using the WHO criteria (Sabia et al. [@CR52]).

Brain Injury {#d30e1244}
------------

Our search of the literature identified traumatic brain injury (TBI) as a potential risk factor for AD. However, the only published meta-analysis reported a pooled estimates for 15 case control studies including 4525 participants (Fleminger et al. [@CR18]). To obtain an estimate based on prospective cohort studies, we identified three publications reporting effect sizes for TBI as a risk factor for AD and estimated a pooled effect size from these (Launer et al. [@CR33]; Plassman et al. [@CR45]; Schofield et al. [@CR57]). The forest plot for this analyses is included online.

Smoking {#d30e1261}
-------

Odds ratios for current versus never smokers, and current versus former smokers were obtained from our previous meta-analysis of 19 prospective studies including 13786 participants followed for AD (Anstey et al. [@CR3]).

Cholesterol {#d30e1269}
-----------

Total serum cholesterol level in mid-life is recognized as a risk factor for AD (Anstey et al. [@CR4]); however, studies vary in how the exposure variable is measured and whether they use self-report or serum measures of high cholesterol. For this study we updated our previously published analyses and derived an odds ratio for self-reported high cholesterol as a risk factor for AD based on the published data for serum levels of cholesterol (National Institutes of Health [@CR43]). We chose a cut-off of \<6.2 (or less than 240 mg/dl) for \"normal\" and \>6.2 for high total cholesterol based on recommendations from the Adult Treatment Panel (ATP) III guidelines (National Institutes of Health [@CR43]) (Solomon et al. [@CR58]). We estimated the odds ratio from a meta-analysis that included the results from articles included in our previously published systematic review (Williams et al. [@CR63]) as well as recently published articles (Mielke et al. [@CR42]; Solomon et al. [@CR58]) and involved follow-up data on 15780 participants (from 5 studies). The forest plot for this analysis is shown in the online supplement.

Physical Activity {#d30e1296}
-----------------

There is consistent evidence that physical activity reduces the risk of AD from meta-analyses (Hamer and Chida [@CR23]; Williams et al. [@CR63]). However, no meta-analysis of physical activity as a risk factor for AD reported information on the exposure variables in a way that could be translated into an available self-report measure of physical activity. Hamer and Chida ([@CR23]) identified only five studies reporting an association between physical activity and AD and only one of these incorporated both intensity and frequency of physical activity (Laurin et al. [@CR34]). This study used questions that had not been validated and were unsuitable for inclusion in the ANU-ADRI.

On the basis that the literature does support the inclusion of physical activity as a protective factor in the ANU-ADRI, we decided to search for odds ratios from studies that reported their findings in relation to specific measures of physical activity that could be incorporated into a questionnaire. Given the aim of the ANU-ADRI for use in clinical trials and to guide advice on risk reduction, we aimed to include three levels of physical activity in the questionnaire, and hence odds ratios needed to be available for medium and high levels of physical activity compared to none. Only one study was identified that reported odds ratios for levels of activity that included a full range of categories and could be translated into cut-offs on a questionnaire (Scarmeas et al. [@CR56]). Hence these odds ratios were selected. The Scarmeas et al. ([@CR56]) study used the Gordin Leisure time exercise questionnaire and this measure has shown a strong association with the International Physical Activity Questionnaire (IPAQ) (Sandroff et al. [@CR55]; Weikert et al. [@CR62]). Scarmeas et al. defined three levels of physical activity using Metabolic Equivalent (MET). For the ANU-ADRI we chose the IPAQ as a measure of physical activity because it includes a more detailed assessment than the Gordin scale, and unlike the Gordin scale has been validated in 12 countries ensuring greater generalizeability and validity of the items (Craig et al. [@CR15]). The ANU-ADRI point system defines three levels of physical activity using MET values according to the IPAQ scoring guidelines.

Alcohol Consumption {#d30e1330}
-------------------

Odds ratios for alcohol consumption were obtained from our meta-analysis of 15 studies including 14646 participants (Anstey et al. [@CR5]). This review showed that alcohol abstainers had an increased risk of AD compared to light to moderate drinkers. In this review, reference categories were based on those used in our meta-analysis which corresponded to the current Australian National Health and Medical Research Council categories. In the ANU-ADRI, the AUDIT questionnaire is used to assess the number of drinks per week and this instrument provides the information required to generate the alcohol consumption categories associated with the odds ratios reported in our review.

Fish Consumption {#d30e1339}
----------------

The only dietary factor reliably linked to the risk of AD was fish consumption. This was found to be protective against cognitive decline and AD (Barberger-Gateau et al. [@CR9]; Huang et al. [@CR26]; Williams et al. [@CR63]). A recent review of five cohort studies reported that four showed a protective effect of fish intake or long-chain omega-3 fatty acid supplements on AD. It was not possible to pool these estimates of the effect of fish intake on AD because of differences between studies in the measure of exposure to fish, and the reporting of results. For the purpose of the ANU-ADRI, individual study questionnaires were reviewed to identify the most suitable self-report questions that assess fish intake that had been validated, and was freely available. Based on this review the questions and odds ratios for fish consumption were selected from the Cardiovascular Health Study (Huang et al. [@CR26]).

Cognitive Activity {#d30e1356}
------------------

Cognitive activity was identified by Williams et al. ([@CR63]) as a factor that reduced the risk of AD. Two large cohort studies reported a reduced risk of AD in older adults who engage in cognitively stimulating activities (Akbaraly et al. [@CR2]; Wilson et al. [@CR64]). The odds ratio for cognitive activity was calculated from these two studies, with data obtained from authors for one study (Wilson et al. [@CR64]). (Forest plot included in online supplement). Both studies used similar methodology to evaluate exposure level. The questionnaire developed for the Rush Memory and Aging Project has been used in three studies by the same research group and has adequate short-term temporal stability and internal consistency. It was therefore chosen for inclusion in the ANU-ADRI; however, items were adapted to include online cognitive activities (e.g., accessing libraries online in addition to in person).

Social Engagement {#d30e1373}
-----------------

Social engagement was identified by the Williams report as protective against Alzheimer's disease with results available from four large cohort studies reporting effect sizes for social engagement (Bassuk et al. [@CR12]; Fratiglioni et al. [@CR20]; Helmer et al. [@CR25]; Saczynski et al. [@CR54]). Two of these used similar measures (HAAS and Kungsholmen) and data from these were pooled (see online supplement) to obtain the odds ratios for the ANU-ADRI (Fratiglioni et al. [@CR20]; Saczynski et al. [@CR54]). The social network measure included marital status, size and quality of social network, level of social activities and living arrangements for both studies and the same measure was included in the ANU-ADRI.

Occupational Exposure to Pesticide {#d30e1397}
----------------------------------

Occupational exposure to pesticide as a risk factor for AD was identified in the review by Williams et al. ([@CR63]). We identified an additional article reporting an odds ratio for occupational pesticide exposure (Baldi et al. [@CR8]; Hayden et al. [@CR24]; Tyas et al. [@CR59]) and a pooled estimate was calculated based on these (included in the online supplement). Questions were developed specifically for the ANU-ADRI.

Variables Not Included {#d30e1414}
----------------------

Several studies reported that coronary artery disease was a risk factor for AD; however, this factor was measured using incompatible methods and meta-analysis of findings was not possible. There is still not enough evidence to evaluate whether ischemic heart disease (including myocardial infarction, angina, and stroke) is a risk factor for AD. With respect to stroke it is difficult to differentiate between AD and post-stroke vascular AD and we did not find any systematic review that could clarify this issue. There is still no firm evidence that hypertension is a risk factor for AD according to the most recent meta-analysis (Power et al. [@CR46]). While ethnicity is included in a previous dementia risk index (Reitz et al. [@CR49]), there is no meta-analysis of ethnicity and it is unknown whether this finding generalizes to other studies or the population. We identified no meta-analysis of self-reported family history of AD based on prospective studies, despite one meta-analysis of case control studies finding an association (van Duijn et al. [@CR60]).

Assumptions Made in the ANU-ADRI {#Sec9}
--------------------------------

Due to the limitations of available evidence specific assumptions are made in the ANU-ADRI that will be evaluated in later versions as more data become available. Assumptions are made about the equivalence for most risk factors for males and females as few studies report odds ratios for males distinct from females. Some assumptions are made about the effect of some risk factors occurring at ages younger than that observed in the studies from which odds ratios were obtained. These assumptions were considered carefully based on available knowledge of the mechanisms by which risk factors may affect AD. For example, the systematic review of smoking included mostly studies of older adults so that the odds ratios reported in Anstey et al. ([@CR3]) apply to older adults but not middle-aged adults. However, no age limit is specified for smoking in the ANU-ADRI. This is because the ANU-ADRI is aimed to assess risk of AD on the assumption that a person's risk profile remained constant until old age. (i.e., if an individual who smokes in late-middle age does not give up smoking then their risk of AD in old age will increase by 79 %). Assumptions were also made in relation to the equivalence of clinical and self-report measures of high cholesterol in order to apply the risk ratio from studies using serum cholesterol to the self-report data on high cholesterol. The additive nature of the algorithm developed to compute the ANU-ADRI assumes that the interactions between risk factors are negligible. The analyses from individual cohort studies reporting associations between risk factors and AD adjust for covariates, which to some extent controls for possible covariation. This assumption of additivity of risk factors can be tested when validation studies of the ANU-ADRI are conducted.

Comparison with Previous AD Risk Assessment Tools {#Sec10}
-------------------------------------------------

Reitz et al. ([@CR49]) focused on vascular risk factors for AD. Of the 11 risk factors included in their AD risk score, 6 could be ascertained by self-report including age, sex, education, ethnicity, diabetes, heart disease. The odds ratio for diabetes was higher in this study than that derived from meta-analyses and used in the ANU-ADR (2.04 vs 1.39). This study did not find smoking significantly associated with risk of AD but included ethnicity and heart disease which are not included in the ANU-ADRI. Jessen et al. found five variables predicted conversion to AD, three of which could be assessed by self-report (age, memory complaint and difficulties with instrumental activities of daily living). The latter two could be caused by AD and hence are not necessarily independent risk factors.

Discussion {#Sec11}
==========

We report a new methodology for developing evidence-based risk assessment tools focussing on the risk assessment of AD. This method is comprehensive, and incorporates a life-course perspective into risk assessment by allowing for risk and protective factors to interact with age. We argue that this evidence-based approach to risk assessment for a chronic disease that is highly prevalent in late-life provides the best foundation for prevention programs aimed at reducing population-prevalence through targeted risk reduction. An evidence-based risk assessment incorporating age-specific effects may also be used to provide individual tailored advice by primary care physicians in counselling patients. We acknowledge that there is also a role for risk assessment tools incorporating clinical measures that are predictive of disease or indicative of pre-clinical dementia but this falls outside the aims of the current study.

Our approach identified far more risk and protective factors than previous studies that have developed risk indices based on individual cohort studies. This increases the utility of the instrument for use in population-based primary prevention programs. It may be used to screen individuals to identify those at high risk of AD who would benefit most from intervention programs. The tool may also be used as an outcome measure for randomized controlled trials of AD risk reduction. The methodology we have presented provides a framework for continual updating and improving of the risk assessment. As more studies are published, the odds ratios can be recalculated and the scoring algorithm updated. As new risk and protective factors are identified they can be added. This methodology could be applied in other settings where there is a need to develop population-level approaches to prevention and incorporate information on risk factors that varies over the life-course.

Biological mechanisms for most of the risk factors included in the ANU-ADRI have been identified or else biologically plausible pathways have been outlined and are described elsewhere. For example, the proposed pathophysiological mechanisms underlying the role of diabetes in the development of AD include endocrine, metabolic and vascular abnormalities and dysfunctions (Biessels et al. [@CR13]). TBI is thought to increase the risk of AD by accelerating amyloid deposition (Kidd [@CR30]). The protective effect of alcohol has been demonstrated in a mouse model and has been attributed to the attenuation of β neuropathy following alcohol consumption (Wang et al. [@CR61]). The mechanisms by which social and cognitive stimulation are thought to reduce the risk of AD remain unknown but are thought to involve neurogenesis resulting from neurostimulation (Redolat and Mesa-Gresa [@CR48]), and down regulation of stress pathways (Rodriguez et al. [@CR51]).

Our survey of the literature did not identify any study that includes all the exposure variables measured by the ANU-ADRI; hence, we expect that validation studies will underestimate the predictive validity of the index. This research however may be used to guide the design of ongoing and new cohort studies focusing in cognitive decline and dementia as outcomes. Estimation of predictive validity from existing datasets containing large numbers of risk and protective factors is the best method available to assess the utility of the index, and to derive valid ranges on the index that correspond to 'low risk,' 'moderate risk' and 'high risk'. External validation of the ANU-ADRI on three such cohort studies is in progress.
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